Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hodgkin's disease and age.

L Specht1, N I Nissen

  • 1Department of Medicine, Finsen Institute, Rigshospitalet, Copenhagen, Denmark.

European Journal of Haematology
|August 1, 1989
PubMed
Summary

Age is not a significant prognostic factor for Hodgkin's disease survival. Treatment, stage, and tumor burden are key indicators for disease-free survival in Hodgkin's patients.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Lymphomas: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up.

Annals of oncology : official journal of the European Society for Medical Oncology·2025
Same author

Primary central nervous system lymphomas: EHA-ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up.

Annals of oncology : official journal of the European Society for Medical Oncology·2024
Same author

Prediction of Radiation-induced Lymphopenia following Exposure of the Thoracic Region and Associated Risk of Infections and Mortality.

Clinical oncology (Royal College of Radiologists (Great Britain))·2023
Same author

Cutaneous Lymphomas.

Clinical oncology (Royal College of Radiologists (Great Britain))·2019
Same author

Primary cutaneous lymphomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

Annals of oncology : official journal of the European Society for Medical Oncology·2018
Same author

Impact of Time to Treatment Initiation in Patients with Human Papillomavirus-positive and -negative Oropharyngeal Squamous Cell Carcinoma.

Clinical oncology (Royal College of Radiologists (Great Britain))·2018

Area of Science:

  • Oncology
  • Clinical Medicine
  • Epidemiology

Background:

  • Hodgkin's disease is a cancer of the lymphatic system.
  • Prognostic factors for Hodgkin's disease require continuous evaluation.
  • Understanding survival predictors is crucial for patient management.

Purpose of the Study:

  • To identify independent prognostic factors for disease-free survival and overall survival in Hodgkin's disease.
  • To evaluate the prognostic significance of various clinical and laboratory parameters.
  • To assess the impact of age on Hodgkin's disease prognosis.

Main Methods:

  • Multivariate analysis of 506 previously untreated Hodgkin's disease patients.
  • Inclusion of factors: age, sex, stage, systemic symptoms, histology, nodal regions, tumor burden, ESR, lymphocytopenia, and treatment modality.
  • Longitudinal follow-up for disease-free and overall survival.

Main Results:

  • Treatment modality, stage, and total tumor burden were independent predictors of disease-free survival.
  • Age did not show independent prognostic significance for disease-free survival.
  • Age and total tumor burden were independent predictors of death from Hodgkin's disease.

Conclusions:

  • Hodgkin's disease prognosis is primarily determined by treatment, stage, and tumor burden.
  • Age is not a significant independent prognostic factor for disease-free survival.
  • Older patients with Hodgkin's disease have a similar prognosis to younger patients, with age-related survival differences potentially linked to treatment access for relapsed disease.

Related Experiment Videos